Meat, milk, saturated fatty acids, the Pro12Ala and C161T polymorphisms of the PPARγ gene and colorectal cancer risk in Japanese

Cancer Science

Volumn 97, Issue 11, 2006, Pages 1226-1235

  Kuriki, Kiyonori ^a   Hirose, Kaoru ^a   Matsuo, Keitaro ^a   Wakai, Kenji ^a   Ito, Hidemi ^a   Kanemitsu, Yukihide ^a   Hirai, Takashi ^a   Kato, Tomoyuki ^a   Hamajima, Nobuyuki ^b   Takezaki, Toshiro ^c   Suzuki, Takeshi ^a   Saito, Toshiko ^a   Tanaka, Rie ^a   Tajima, Kazuo ^a  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROLINE; SATURATED FATTY ACID;

ADULT; AGED; ARTICLE; CANCER GENETICS; CANCER RISK; CASE CONTROL STUDY; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; FOOD INTAKE; FOOD PREFERENCE; GENE FREQUENCY; GENOTYPE; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; MEAT; MILK; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; QUESTIONNAIRE; RISK ASSESSMENT;

ADULT; AGED; ANIMALS; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; FATTY ACIDS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; JAPAN; MALE; MEAT; MIDDLE AGED; MILK; POLYMORPHISM, GENETIC; PPAR GAMMA; QUESTIONNAIRES; RISK FACTORS;

EID: 33748948953     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2006.00314.x     Document Type: Article

References (57)

1. Tontonoz P, Hu E, Spiegelman BM. Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell 1994; 79: 1147-56.
2. Kersten S, Desvergne B, Wahli W. Roles of PPARs in health and disease. Nature 2000; 405: 421-4.
3. DuBois RN, Gupta R, Brockman J et al. The nuclear eicosanoid receptor, PPARs, is aberrantly expressed in colonic cancers. Carcinogenesis 1998; 19: 49-53.
4. Yanase T, Yashiro T, Takitani K et al. Differential expression of PPAR gamma1 and gamma2 isoforms in human adipose tissue. Biochem Biophys Res Commun 1997; 233: 320-4.
5. Fajas L, Auboeuf D, Raspe E et al. The organization, promoter analysis, and expression of the human PPARγ gene. J Biol Chem 1997; 272: 18779-89.
6. Martin G, Schoonjans K, Lefebvre AM, Staels B, Auwerx J. Coordinate regulation of the expression of the fatty acid transport protein and acyl-CoA synthetase genes by PPARalpha and PPARgamma activators. J Biol Chem 1997; 272: 28210-7.
7. Kliewer SA, Xu HE, Lambert MH, Willson TM. Peroxisome proliferator-activated receptors: From genes to physiology. Recent Prog Horm Res 2001; 56: 239-63.
8. Werman A, Hollenberg A, Solanes G et al. Ligand-independent activation domain in the N terminus of peroxisome proliferator-activated receptor gamma (PPARγ). Differential activity of PPARγ-1 and -2 isoforms and influence of insulin. J Biol Chem 1997; 272: 20230-5.
9. Deeb SS, Fajas L, Nemoto M et al. A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet 1998; 20: 284-7.
10. Koeffler HP. Peroxisome proliferator-activated receptor gamma and cancers. Clin Cancer Res 2003; 9: 1-9.
11. Kuriki K, Tokudome S, Tajima K. Association between type II diabetes and colon cancer among Japanese with reference to changes in food intake. Asian Pac J Cancer Prev 2004; 5: 28-35.
12. Auwerx J. PPARγ, the ultimate thrifty gene. Diabetologia 1999; 42: 1033-49.
13. Kubota N, Terauchi Y, Miki H et al. PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Mol Cell 1999; 4: 597-609.
14. Memisoglu A, Hu FB, Hankinson SE et al. Interaction between a peroxisome proliferator-activated receptor gamma gene polymorphism and dietary fat intake in relation to body mass. Hum Mol Genet 2003; 12: 2923-9.
15. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB. Cancer Incidence in Five Continents VIII, no. 155. Lyon: IARC, 2002.
16. Nemoto M, Sasaki T, Deeb SS, Fujimoto WY, Tajima N. Differential effect of PPARγ2 variants in the development of type 2 diabetes between native Japanese and Japanese Americans. Diabetes Res Clin Pract 2002; 57: 131-7.
17. Hara K, Okada T, Tobe K et al. The Pro12Ala polymorphism in PPAR gamma2 may confer resistance to type 2 diabetes. Biochem Biophys Res Commun 2000; 271: 212-6.
18. Mori Y, Kim-Motoyama H, Katakura T et al. Effect of the Pro12Ala variant of the human peroxisome proliferator-activated receptor gamma 2 gene on adiposity, fat distribution, and insulin sensitivity in Japanese men. Biochem Biophys Res Commun 1998; 251: 195-8.
19. Murtaugh MA, Ma KN, Caan BJ et al. Interactions of peroxisome proliferator-activated receptor {gamma} and diet in etiology of colorectal cancer. Cancer Epidemiol Biomarkers Prev 2005; 14: 1224-9.
20. Siezen CL, van Leeuwen AI, Kram NR et al. Colorectal adenoma risk is modified by the interplay between polymorphisms in arachidonic acid pathway genes and fish consumption. Carcinogenesis 2005; 26: 449-57.
21. Landi S, Moreno V, Gioia-Patricola L et al. Association of common polymorphisms in inflammatory genes interleukin (IL) 6, IL8, tumor necrosis factor alpha, NFκB1, and peroxisome proliferator-activated receptor gamma with colorectal cancer. Cancer Res 2003; 63: 3560-6.
22. Slattery ML, Murtaugh MA, Sweeney C et al. PPARγ, energy balance, and associations with colon and rectal cancer. Nutr Cancer 2005; 51: 155-61.
23. Meirhaeghe A, Fajas L, Helbecque N et al. A genetic polymorphism of the peroxisome proliferator-activated receptor gamma gene influences plasma leptin levels in obese humans. Hum Mol Genet 1998; 7: 435-40.
24. Wang XL, Oosterhof J, Duarte N. Peroxisome proliferator-activated receptor gamma C161 -> T polymorphism and coronary artery disease. Cardiovasc Res 1999; 44: 588-94.
25. Yen CJ, Beamer BA, Negri C et al. Molecular scanning of the human peroxisome proliferator activated receptor gamma (PPARγ) gene in diabetic Caucasians: Identification of a Pro12Ala PPAR gamma 2 missense mutation. Biochem Biophys Res Commun 1997; 241: 270-4.
26. Valve R, Sivenius K, Miettinen R et al. Two polymorphisms in the peroxisome proliferator-activated receptor-gamma gene are associated with severe overweight among obese women. J Clin Endocrinol Metab 1999; 84: 3708-12.
27. Hamajima N, Matsuo K, Saito T et al. Gene-environment interactions and polymorphism studies of cancer risk in the Hospital-based Epidemiologic Research Program at Aichi Cancer Center II (HERPACC-II). Asian Pac J Cancer Prev 2001; 2: 99-107.
28. Kuriki K, Hamajima N, Chiba H et al. Increased risk of colorectal cancer due to interactions between meat consumption and the CD36 gene A52C polymorphism among Japanese. Nutr Cancer 2005; 51: 170-7.
29. Inoue M, Tajima K, Hirose K et al. Epidemiological features of first-visit outpatients in Japan: Comparison with general population and variation by sex, age, and season. J Clin Epidemiol 1997; 50: 69-77.
30. Tokudome S, Ikeda M, Tokudome Y et al. Development of data-based semi-quantitative food frequency questionnaire for dietary studies in middle-aged Japanese. Jpn J Clin Oncol 1998; 28: 679-87.
31. Tokudome S, Goto C, Imaeda N et al. Development of a data-based short food frequency questionnaire for assessing nutrient intake by middle-aged Japanese. Asian Pac J Cancer Prev 2004; 5: 40-3.
32. Tokudome Y, Goto C, Imaeda N et al. Relative validity of a short food frequency questionnaire for assessing nutrient intake versus three-day weighed diet records in middle-aged Japanese. J Epidemiol 2005; 15: 135-45.
33. Goto C, Tokudome Y, Imaeda N et al. Validation study of fatty acid consumption assessed with a short food frequency questionnaire against plasma concentration in middle-ages Japanese people. Scand J Nutr 2006; 50: 70-82.
34. Hamajima N, Saito T, Matsuo K et al. Polymerase chain reaction with confronting two-pair primers for polymorphism genotyping. Jpn J Cancer Res 2000; 91: 865-8.
35. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001; 68: 978-89.
36. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263-5.
37. Ministry of Health, Labor and Welfare, Division of Health and Nutrition. Kokumin-Eiyo-no-Genjo [Current Status of National Nutrition] 2000. Tokyo: Dai-ichi Shuppann, 2002 (in Japanese).
38. World Cancer Research Fund/American Institute for Cancer Research. Colon, Rectum. In: American Institute for Cancer Research, ed. Food, Nutrition and the Prevention of Cancer: A Global Perspective. Washington, DC: American Institute for Cancer Research, 1997; 216-51.
39. Chen GG, Lee JF, Wang SH et al. Apoptosis induced by activation of peroxisome-proliferator activated receptor-gamma is associated with Bcl-2 and NF-κB in human colon cancer. Life Sci 2002; 70: 2631-46.
40. Vanden Heuvel JP. Peroxisome proliferator-activated receptors: A critical link among fatty acids, gene expression and carcinogenesis. J Nutr 1999; 129: S575-80.
41. Auwerx J. Nuclear receptors. I. PPARγ in the gastrointestinal tract: Gain or pain? Am J Physiol Gastrointest Liver Physiol 2002; 282: G581-5.
42. Osawa E, Nakajima A, Wada K et al. Peroxisome proliferator-activated receptor gamma ligands suppress colon carcinogenesis induced by azoxymethane in mice. Gastroenterology 2003; 124: 361-7.
43. Sarraf P, Mueller E, Jones D et al. Differentiation and reversal of malignant changes in colon cancer through PPARγ. Nat Med 1998; 4: 1046-52.
44. Lefebvre AM, Chen I, Desreumaux P et al. Activation of the peroxisome proliferator-activated receptor gamma promotes the development of colon tumors in C57BL/6J-APCMin/+ mice. Nat Med 1998; 4: 1053-7.
45. Saez E, Tontonoz P, Nelson MC et al. Activators of the nuclear receptor PPARγ enhance colon polyp formation. Nat Med 1998; 4: 1058-61.
46. Tanaka T, Kohno H, Yoshitani S et al. Ligands for peroxisome proliferator-activated receptors alpha and gamma inhibit chemically induced colitis and formation of aberrant crypt foci in rats. Cancer Res 2001; 61: 2424-8.
47. Vamecq J, Latruffe N. Medical significance of peroxisome proliferator-activated receptors. Lancet 1999; 354: 141-8.
48. Cho E, Smith-Warner SA, Spiegelman D et al. Dairy foods, calcium, and colorectal cancer: A pooled analysis of 10 cohort studies. J Natl Cancer Inst 2004; 96: 1015-22.
49. Ma J, Giovannucci E, Pollak M et al. Milk intake, circulating levels of insulin-like growth factor-I, and risk of colorectal cancer in men. J Natl Cancer Inst 2001; 93: 1330-6.
50. Kojima M, Wakai K, Tamakoshi K et al. Diet and colorectal cancer mortality: Results from the Japan Collaborative Cohort Study. Nutr Cancer 2004; 50: 23-32.
51. Tokudome Y, Imaeda N, Ikeda M et al. Foods contributing to absolute intake and variance in intake of fat, fatty acids and cholesterol in middle-aged Japanese. J Epidemiol 1999; 9: 78-90.
52. Rocchi S, Auwerx J. Peroxisome proliferator-activated receptor gamma, the ultimate liaison between fat and transcription. Br J Nutr 2000; 84: S223-7.
53. Field CJ, Ryan EA, Thomson AB, Clandinin MT. Dietary fat and the diabetic state alter insulin binding and the fatty acyl composition of the adipocyte plasma membrane. Biochem J 1998; 253: 417-24.
54. Luan J, Browne PO, Harding AH et al. Evidence for gene-nutrient interaction at the PPARγ locus. Diabetes 2001; 50: 686-9.
55. Jiang J, Gajalakshmi V, Wang J et al. Influence of the C161T but not Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma on colorectal cancer in an Indian population. Cancer Sci 2005; 96: 507-12.
56. Hamajima N, Hirose K, Inoue M et al. Age-specific risk factors of breast cancer estimated by a case-control study in Japan. J Epidemiol 1995; 5: 99-105.
57. Yang CX, Matsuo K, Ito H et al. Gene-environment interactions between alcohol drinking and the MTHFR C677T polymorphism impact on esophageal cancer risk: Results of a case-control study in Japan. Carcinogenesis 2005; 26: 1285-90.